Dr. Arnold S. Baas, MD

Dr. Baas practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Baas' NPI, 1720013717, was assigned on July 11, 2006. Dr. Baas graduated from University of Texas Southwestern Medical School at Dallas in 1989. Dr. Baas holds California license C51919.

Dr. Baas' primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Baas' primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Baas is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Baas to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baas practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Baas' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Baas is board certified in certification board of cardiovascular computed tomography (cbcct) by the Alliance for Physician Certification & Advancement. Dmand AI has Dr. Baas' licenses on file in 2 states: California and Michigan.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Baas treats.

CMS data shows 4,194 Medicare services from Dr. Baas across 20 procedure codes in 2024, for 975 Medicare patients. Medicare paid $251,917 for them.

CMS counts 975 Medicare patients who saw Dr. Baas in 2024. The largest group is 65 to 74, with 357 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baas' median patient age at 65, with 35% women.

In 2024, Dr. Baas wrote 5,621 Medicare Part D claims for 550 patients. 79% of them were for generic drugs. CMS names the drug for 5,231 of them, across 69 drugs with 11 or more claims each, at $2,692,832 in total drug cost. In 2023, CMS named 4,413 claims across 69 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Baas for performance year 2024, reported as part of a group. Dr. Baas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Baas as offering telehealth.

Dmand AI links 5 papers to Dr. Baas, published from 2017 to 2021. 2019 was the busiest year, with 2. Dr. Baas' most frequent co-authors are Daniel Cruz, MD, Mario Chih-Hsiung Karl Deng, MD and Murray H. Kwon, MD.

Dmand AI links Dr. Baas to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 14 general payments to Dr. Baas from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic Vascular, Inc. paid the most, $265.

Dmand AI lists 2 awards for Dr. Baas.

Dr. Baas graduated from University of Texas Southwestern Medical School at Dallas in 1989. Dr. Baas is a member of ACC, ACP, AHA, ASE, ASH and Heart Failure Society of America.

Dr. Baas is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.